In this episode, I interview Michelle Gallaher, a Melbourne-based award-winning entrepreneur, speaker, and advocate for the Australian health technology sector and for women in science, technology, engineering maths, and medicine (STEMM). As CEO of Opyl Ltd (ASX:OPL), a company...
146: With over a decade of extensive experience in biotechnology and life science space, now leading a pharmaceutical company for over a year, growing market cap from less than $10 million to over $16 million and from 2 to 24 FTEs. (Punit Dhillon)
Oct 06, 2021
Continue Reading...
In this episode, I interview Punit Dhillon, the President, CEO & Chair of Skye Bioscience Inc. based in San Diego, California, USA, a public pharmaceutical company with a leading program in ophthalmology, developing a drug for glaucoma. Punit is a biotech and life sciences entrepreneur...
